Srn Advisors, LLC Merck & Co., Inc. Transaction History

Srn Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jun 14, 2024	SELL	$72.28 - $90.54 $474,807 - $594,757	-6,569 Closed	0 $0
Q3 2021 Jun 14, 2024	SELL	$71.68 - $78.83 $801,310 - $881,240	-11,179 Reduced 62.99%	6,569 $493 Million
Q2 2021 Jun 14, 2024	SELL	$70.31 - $77.77 $126,628 - $140,063	-1,801 Reduced 9.21%	17,748 $1.38 Billion
Q1 2021 Jun 14, 2024	SELL	$68.86 - $81.11 $277,643 - $327,035	-4,032 Reduced 17.1%	19,549 $1.51 Billion
Q4 2020 Jun 14, 2024	BUY	$71.77 - $79.65 $1.69 Million - $1.88 Million	23,581 New	23,581 $1.9 Billion

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Srn Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Srn Advisors, LLC with notifications on news.